As shown in Fig. 2b, c, CD28 in ACH patients was significantly higher than in ACs, HDs or HCC patients (p < 0.05), and CD28 in Cir patients was higher than in ACs or HCC patients (p < 0.05). Here, CD28 is linked to hepatocellular carcinoma.